The role of gabapentin in treating disea
β
Noah Scheinfeld
π
Article
π
2003
π
John Wiley and Sons
π
English
β 86 KB
## Abstract **Background** Gabapentin was first approved by the FDA in 1993 as an addβon treatment for partial epileptic seizures. In May of 2002, it was approved as treatment for postβherpetic neuralgia by the Food and Drug Adminstration. It appears to be a promising agent in the treatment of pain